OptimizeRx

OPRX

Market cap $369M

Healthcare stocks quietly outperformed the market in the past 30 days as headlines centered on the government shutdown over the extension of Affordable Care Act tax credits for 2026. The AI in healthcare market is expected to reach $504B by 2032, driven by an aging population, medical data explosion, job shortages, and consumer demand for self-care technology. Healthcare companies are increasingly deploying AI in drug discovery, diagnostics, imagery, robot-assisted surgery, and hospital administration.

OptimizeRx Corporation is evolving from an EHR messaging platform to a clinical data and AI-driven advertising company, leveraging DAAP and MNT technologies. Q2 2025 financials show strong revenue growth, improved margins, and a shift to higher-margin subscription revenues, supporting management's raised guidance for 2025. The Lamar partnership and expanding mid-tier pharma client base diversify revenue streams, reduce risk, and confirm OPRX's strategic pivot to broader advertising markets.

Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.

WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 11, 2025, in New York, NY.

Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood ® Targeting Data with Lamar's Vast Nationwide OOH Network to  Strengthen OOH Media for Healthcare Marketing

OPRX, KT and GLDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 5, 2025.

OPRX, PHIN and KT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3, 2025.

Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

OptimizeRx (OPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).